Elevance Health Inc (ELV) Stock Analysis
Verdict: HOLD
Steady top-line scale and C-suite insider buying anchor defensiveness, but compressed margins (2.5% net) and $33.2B debt cap rapid upside.
Investment score: 63/100
Analysis as of
Is Elevance Health Inc stock worth reviewing? AI model thesis
The model score of 63/100 falls in the HOLD range. The central thesis and factor breakdown explain the assessment.
7-factor investment score
- Valuation: 62/100 (weight 20%)
- Financial Health: 50/100 (weight 15%)
- Technical Momentum: 72/100 (weight 15%)
- Earnings Quality: 55/100 (weight 15%)
- Insider Sentiment: 80/100 (weight 10%)
- Analyst Consensus: 62/100 (weight 10%)
- Risk-Adjusted Return: 65/100 (weight 15%)
Elevance Health Inc opportunities and risks
What speaks for ELV
- Carelon Ecosystem Monetization
What speaks against ELV
- Free Cash Flow Contraction
Frequently asked questions about Elevance Health Inc (ELV)
Is ELV stock a good investment?
The cached TradeMates AI model rates Elevance Health Inc as HOLD with an investment score of 63/100. The model score of 63/100 falls in the HOLD range. The central thesis and factor breakdown explain the assessment. This is algorithmic model output, not personal investment advice.
Is ELV stock a buy?
The TradeMates model verdict for ELV is HOLD with an investment score of 63/100. Treat this as a model signal to review, not a personal buy recommendation.